53 related articles for article (PubMed ID: 16620115)
1. In silico discovery of beta-secretase inhibitors.
Huang D; Lüthi U; Kolb P; Cecchini M; Barberis A; Caflisch A
J Am Chem Soc; 2006 Apr; 128(16):5436-43. PubMed ID: 16620115
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and in vitro evaluation studies of sulfonyl-amino-acetamides as small molecule BACE-1 inhibitors.
Jain P; Wadhwa PK; Gunapati S; Jadhav HR
Bioorg Med Chem; 2016 Jun; 24(11):2567-2575. PubMed ID: 27102162
[TBL] [Abstract][Full Text] [Related]
3. Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach.
Barbosa DB; do Bomfim MR; de Oliveira TA; da Silva AM; Taranto AG; Cruz JN; de Carvalho PB; Campos JM; Santos CBR; Leite FHA
Pharmaceuticals (Basel); 2023 Nov; 16(12):. PubMed ID: 38139784
[TBL] [Abstract][Full Text] [Related]
4.
Ullah H; Zhang B; Sharma NK; McCrea PD; Srivastava Y
Front Mol Biosci; 2022; 9():981020. PubMed ID: 36090034
[TBL] [Abstract][Full Text] [Related]
5. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design.
Kumar A; Tiwari A; Sharma A
Curr Neuropharmacol; 2018; 16(6):726-739. PubMed ID: 29542413
[TBL] [Abstract][Full Text] [Related]
6. Combining in vitro and in silico Approaches to Find New Candidate Drugs Targeting the Pathological Proteins Related to the Alzheimer's Disease.
Li H; Wang X; Yu H; Zhu J; Jin H; Wang A; Yang Z
Curr Neuropharmacol; 2018; 16(6):758-768. PubMed ID: 29086699
[TBL] [Abstract][Full Text] [Related]
7. A Simple PB/LIE Free Energy Function Accurately Predicts the Peptide Binding Specificity of the Tiam1 PDZ Domain.
Panel N; Sun YJ; Fuentes EJ; Simonson T
Front Mol Biosci; 2017; 4():65. PubMed ID: 29018806
[TBL] [Abstract][Full Text] [Related]
8. BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.
Ghosh AK; Osswald HL
Chem Soc Rev; 2014 Oct; 43(19):6765-813. PubMed ID: 24691405
[TBL] [Abstract][Full Text] [Related]
9. Structure-based discovery of antagonists of nuclear receptor LRH-1.
Benod C; Carlsson J; Uthayaruban R; Hwang P; Irwin JJ; Doak AK; Shoichet BK; Sablin EP; Fletterick RJ
J Biol Chem; 2013 Jul; 288(27):19830-44. PubMed ID: 23667258
[TBL] [Abstract][Full Text] [Related]
10. Effect of pH and ligand charge state on BACE-1 fragment docking performance.
Domínguez JL; Villaverde MC; Sussman F
J Comput Aided Mol Des; 2013 May; 27(5):403-17. PubMed ID: 23640428
[TBL] [Abstract][Full Text] [Related]
11. Monitoring β-secretase activity in living cells with a membrane-anchored FRET probe.
Folk DS; Torosian JC; Hwang S; McCafferty DG; Franz KJ
Angew Chem Int Ed Engl; 2012 Oct; 51(43):10795-9. PubMed ID: 23023944
[No Abstract] [Full Text] [Related]
12. Exploring the binding of BACE-1 inhibitors using comparative binding energy analysis (COMBINE).
Liu S; Fu R; Cheng X; Chen SP; Zhou LH
BMC Struct Biol; 2012 Aug; 12():21. PubMed ID: 22925713
[TBL] [Abstract][Full Text] [Related]
13. Application of consensus scoring and principal component analysis for virtual screening against β-secretase (BACE-1).
Liu S; Fu R; Zhou LH; Chen SP
PLoS One; 2012; 7(6):e38086. PubMed ID: 22701601
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of several two-step scoring functions based on linear interaction energy, effective ligand size, and empirical pair potentials for prediction of protein-ligand binding geometry and free energy.
Rahaman O; Estrada TP; Doren DJ; Taufer M; Brooks CL; Armen RS
J Chem Inf Model; 2011 Sep; 51(9):2047-65. PubMed ID: 21644546
[TBL] [Abstract][Full Text] [Related]
15. SwissDock, a protein-small molecule docking web service based on EADock DSS.
Grosdidier A; Zoete V; Michielin O
Nucleic Acids Res; 2011 Jul; 39(Web Server issue):W270-7. PubMed ID: 21624888
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of BACE1 for therapeutic use in Alzheimer's disease.
Luo X; Yan R
Int J Clin Exp Pathol; 2010 Jul; 3(6):618-28. PubMed ID: 20661410
[TBL] [Abstract][Full Text] [Related]
17. BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.
Marks N; Berg MJ
Neurochem Res; 2010 Feb; 35(2):181-210. PubMed ID: 19760173
[TBL] [Abstract][Full Text] [Related]
18. Docking screens: right for the right reasons?
Kolb P; Irwin JJ
Curr Top Med Chem; 2009; 9(9):755-70. PubMed ID: 19754393
[TBL] [Abstract][Full Text] [Related]
19. Comparative molecular field analysis and comparative molecular similarity indices analysis of hydroxyethylamine derivatives as selective human BACE-1 inhibitor.
Pandey A; Mungalpara J; Mohan CG
Mol Divers; 2010 Feb; 14(1):39-49. PubMed ID: 19330459
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.
Ekonomiuk D; Su XC; Ozawa K; Bodenreider C; Lim SP; Yin Z; Keller TH; Beer D; Patel V; Otting G; Caflisch A; Huang D
PLoS Negl Trop Dis; 2009; 3(1):e356. PubMed ID: 19159012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
